{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:35:00Z","timestamp":1793313300556,"version":"4.5.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["DA045848"],"award-info":[{"award-number":["DA045848"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["P20GM125507"],"award-info":[{"award-number":["P20GM125507"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.josat.2023.209195","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T12:41:29Z","timestamp":1697546489000},"page":"209195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pharmacy-based expansion of buprenorphine access"],"prefix":"10.1016","volume":"157","author":[{"given":"Seth A.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci C.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiah D.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.209195_bb0005","author":"Ahmad"},{"issue":"4","key":"10.1016\/j.josat.2023.209195_bb0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4066\/AMJ.2011.706","article-title":"Provision of opioid substitution therapy services in Australian pharmacies","volume":"4","author":"Chaar","year":"2011","journal-title":"The Australasian Medical Journal"},{"key":"10.1016\/j.josat.2023.209195_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108283","article-title":"Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island","volume":"124","author":"Clark","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2023.209195_bb0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2307\/3343343","article-title":"Prescriptions, power and politics: The turbulent history of methadone maintenance in Canada","volume":"21","author":"Fischer","year":"2000","journal-title":"Journal of Public Health Policy"},{"issue":"2","key":"10.1016\/j.josat.2023.209195_bb0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJMc2208055","article-title":"Physician-delegated unobserved induction with buprenorphine in pharmacies","volume":"388","author":"Green","year":"2023","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.josat.2023.209195_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108729","article-title":"Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden","volume":"224","author":"Kazerouni","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209195_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019","volume":"110","author":"Krawczyk","year":"2022","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2023.209195_bb0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugpo.2015.11.006","article-title":"Community pharmacy services for people with drug problems over two decades in Scotland: Implications for future development","volume":"27","author":"Matheson","year":"2016","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2023.209195_bb0045","article-title":"Outcomes of a mobile medical unit for low-threshold buprenorphine access targeting opioid overdose hot spots in Chicago","volume":"150","author":"Messmer","year":"2023","journal-title":"J Subst Use Addict Treat"},{"issue":"2","key":"10.1016\/j.josat.2023.209195_bb0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/1073110520935353","article-title":"Decriminalization of diverted buprenorphine in Burlington, Vermont and Philadelphia: An intervention to reduce opioid overdose deaths","volume":"48","author":"Pozo","year":"2020","journal-title":"The Journal of Law, Medicine & Ethics"},{"issue":"8","key":"10.1016\/j.josat.2023.209195_bb0055","doi-asserted-by":"crossref","first-page":"e222839","DOI":"10.1001\/jamahealthforum.2022.2839","article-title":"Federal and state pharmacy regulations and dispensing barriers to buprenorphine access at retail pharmacies in the US","volume":"3","author":"Qato","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"5","key":"10.1016\/j.josat.2023.209195_bb0060","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/ajhp\/zxaa390","article-title":"Medicaid reimbursement for pharmacist services: A strategy for the pharmacy profession","volume":"78","author":"Schweitzer","year":"2021","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"1","key":"10.1016\/j.josat.2023.209195_bb0065","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/07853890.2023.2182908","article-title":"Adaptation of the tele-harm reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: A retrospective cohort study","volume":"55","author":"Suarez","year":"2023","journal-title":"Annals of Medicine"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:39:44Z","timestamp":1762652384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":13,"alternative-id":["S2949875923002461"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209195","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacy-based expansion of buprenorphine access","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209195"}}